ENTX (STOCKS)
Entera Bio Ltd. Ordinary Shares
$1.660000
+0.210000 (+14.48%)
Prev close: $1.450000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Miranda J. Toledano
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $105.49M
- Employees
- 21
- P/E (TTM)
- -6.70
- P/B (TTM)
- 4.92
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $124.00K |
| Benefits Costs and Expenses | $9.71M |
| Cost Of Revenue | $124.00K |
| Costs And Expenses | $10.89M |
| Gross Profit | $0.00 |
| Nonoperating Income/Loss | $57.00K |
| Operating Expenses | $10.82M |
| Research and Development | $5.49M |
| Other Operating Expenses | $5.24M |
| Operating Income/Loss | -$10.82M |
| Income/Loss From Continuing Operations After Tax | -$10.78M |
| Income/Loss From Continuing Operations Before Tax | -$2.30M |
| Net Income/Loss | -$10.78M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.78M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.78M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.24 |
| Diluted Earnings Per Share | $0.24 |
| Basic Average Shares | 46,316,202 |
| Diluted Average Shares | 46,316,202 |
| Assets | $17.41M |
| Current Assets | $17.01M |
| Prepaid Expenses | $143.00K |
| Other Current Assets | $16.86M |
| Noncurrent Assets | $400.00K |
| Fixed Assets | $114.00K |
| Other Non-current Assets | $286.00K |
| Liabilities | $2.17M |
| Current Liabilities | $1.57M |
| Accounts Payable | $216.00K |
| Other Current Liabilities | $1.36M |
| Noncurrent Liabilities | $602.00K |
| Equity | $15.23M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $15.23M |
| Liabilities And Equity | $17.41M |
| Net Cash Flow From Operating Activities | -$7.00M |
| Net Cash Flow From Operating Activities, Continuing | -$7.00M |
| Net Cash Flow From Investing Activities | -$4.18M |
| Net Cash Flow From Investing Activities, Continuing | -$4.18M |
| Net Cash Flow From Financing Activities | $16.75M |
| Net Cash Flow From Financing Activities, Continuing | $16.75M |
| Net Cash Flow | $5.60M |
| Net Cash Flow, Continuing | $5.57M |
| Comprehensive Income/Loss | -$10.78M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.78M |
| Other Comprehensive Income/Loss | $0.00 |